{
    "Trade/Device Name(s)": [
        "JBAIDS Anthrax Detection System"
    ],
    "Submitter Information": "Idaho Technology Inc.",
    "510(k) Number": "K051713",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033734"
    ],
    "Regulatory Class": "",
    "Product Code(s)": [
        "NHT",
        "JJF"
    ],
    "Summary Letter Date": "September 29, 2005",
    "Summary Letter Received Date": "October 3, 2005",
    "Submission Date": "November 14, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.2660",
        "21 CFR 862.2170"
    ],
    "Regulation Name(s)": [
        "Microorganism differentiation and identification device",
        "Micro Chemistry Analyzer for Clinical Use"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Bacillus anthracis pXO1 plasmid DNA",
        "Bacillus anthracis pXO2 plasmid DNA"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Blood Culture",
        "Bacterial Culture"
    ],
    "Specimen Container(s)": [
        "Sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "JBAIDS instrument",
        "Laptop computer (JBAIDS software v2.1 or higher)"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Hydrolysis probe detection",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "PCR amplification",
        "Qualitative nucleic acid detection"
    ],
    "Submission Type(s)": [
        "System",
        "Instrument",
        "Reagent Kit",
        "Software",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for the JBAIDS Anthrax Detection System utilizing real-time PCR for qualitative detection of Bacillus anthracis DNA in blood and cultures",
    "Indications for Use Summary": "Qualitative in vitro diagnostic detection of Bacillus anthracis DNA targets (pXO1 and pXO2 plasmids) in whole blood (sodium citrate), positive blood cultures, and cultured organisms on blood agar from individuals suspected of anthrax; used as presumptive identification alongside culture and other laboratory tests",
    "fda_folder": "Microbiology"
}